Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyoscine cervical priming before intrauterine procedures
IRCT20130119012190N6Phase 2Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Dec 2017
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of scopolamine in cervical spinal stenosis (CSS), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Uterine cervix opening size. Started Dec 2017; status: completed.
02
Drugs
scopolamine
03
Conditions
cervical spinal stenosis (CSS)
Beyond the preview
Go deeper on IRCT20130119012190N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130119012190N6.